Merck KGaA (OTCMKTS:MKGAF - Get Free Report) shares saw unusually-strong trading volume on Friday . Approximately 1,144 shares traded hands during trading, an increase of 4% from the previous session's volume of 1,097 shares.The stock last traded at $134.77 and had previously closed at $128.50.
Merck KGaA Price Performance
The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31. The stock has a market cap of $16.96 billion, a price-to-earnings ratio of 20.04 and a beta of 0.96. The company has a 50-day simple moving average of $134.17 and a two-hundred day simple moving average of $139.97.
About Merck KGaA
(
Get Free Report)
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
Featured Articles
Before you consider Merck KGaA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Merck KGaA wasn't on the list.
While Merck KGaA currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
